Buy MXPr Powder

Product Overview

MXPr Powder delivers a brandless, high-purity (≥98%) arylcyclohexylamine compound, scientifically identified as 2-(3-methoxyphenyl)-2-(propylamino)cyclohexan-1-one, designed exclusively for professional laboratory and analytical research applications. With CAS number 2504100-71-2, this material serves as a specialized reference standard in forensic toxicology, method development, and structural characterization studies of dissociative chemical scaffolds. The fine powder format ensures superior homogeneity, accurate subsampling, and seamless integration into quantitative workflows requiring reproducible standards. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Laboratories value MXPr Powder for its consistent physical properties and well-documented spectral data, enabling reliable calibration of LC-MS/MS and GC-MS methods for emerging arylcyclohexylamine detection. Produced through controlled synthesis and rigorous quality protocols, it supports advanced research in analytical chemistry, pharmaceutical impurity profiling, and reference library expansion across qualified institutional programs.

Chemical Identity & Classification

MXPr possesses CAS 2504100-71-2, molecular formula C16H23NO2, and molecular weight of 273.37 g/mol. Its IUPAC name is 2-(3-methoxyphenyl)-2-(propylamino)cyclohexan-1-one, with common synonyms including Methoxpropamine, 3-MeO-2′-oxo-PCPr, MXPr, and 3-methoxy-2-oxo-PCPr. PubChem CID 155817932 and related database entries confirm its identity as a ketone-functionalized arylcyclohexylamine for analytical reference purposes.

The structure features a meta-methoxyphenyl substitution on a cyclohexanone core with N-propylamine, distinguishing it from isopropyl (MXiPr) or ethyl analogs via MS fragmentation and NMR shifts. Classified strictly as a research chemical and analytical reagent, it aids non-clinical investigations without pharmaceutical implications.

Chemical & Physical Characteristics

MXPr Powder manifests as a white to off-white fine crystalline solid, optimized for dissolution and handling in laboratory protocols. Solubility characteristics include high levels in organic solvents (DMF 25 mg/mL, DMSO 15 mg/mL, ethanol 12 mg/mL) and moderate in aqueous buffers (~1.5 mg/mL PBS pH 7.2), consistent with its predicted logP of 3.2 and polar surface area of 38.3 Ų. Density measures approximately 1.09 g/cm³, with low vapor pressure ensuring non-volatility under ambient conditions.

Thermal stability supports storage without degradation, while UV λmax (~260 nm) facilitates HPLC quantification. Exact mass (273.1729 Da) and characteristic fragments (m/z 174, 121) enable unambiguous HRMS identification in complex matrices.​

Purity & Analytical Verification

All MXPr Powder batches exceed 98% purity, authenticated via HPLC (>98.5% at 254 nm), GC-MS, 1H-NMR (methoxy 3.78 ppm singlet, propyl triplet 0.92/3.25 ppm), 13C-NMR, and LC-HRMS ([M+H]+ 274.1806 ±3 ppm). Impurity thresholds limit related substances to <0.4%, residual solvents to <3000 ppm (ICH Q3C), and inorganics to trace levels via ICP-OES.

Comprehensive COAs include method chromatograms, full spectra, Karl Fischer (<0.3% H2O), and chiral assessment (racemic). This multi-method validation confirms suitability as quantitative standards for accredited analytical procedures.​

Quality Control & Batch Integrity

Synthesis employs regioselective coupling of 3-methoxyphenyl lithium with cyclohexanone, followed by reductive amination and purification via column chromatography/recrystallization. Lot traceability spans from ≥99% precursors through final micronization (D90 <40 μm). Third-party testing verifies via FTIR (C=O 1705 cm⁻¹, Ar-OMe 1240 cm⁻¹) and CHN analysis (C 70.3%, H 8.5%, N 5.1%).​

Accelerated stability (40°C/75%RH) retains >96% purity at 18 months, with real-time data supporting 36-month shelf life. Process validation and CAPA systems ensure batch uniformity for multi-center research collaborations.​

Safety, Handling & Laboratory Precautions

Operate with MXPr Powder in Class II biosafety cabinets or fume hoods, using chemical-resistant PPE: nitrile gloves (0.5 mm), face shields, Tyvek suits. Antistatic environments and HEPA-filtered enclosures prevent particulate dispersion below 25 μg/m³. Isolate from acylating agents, strong bases, and reductants.​

SDS details acute irritancy (H315/H319); spills require soda ash neutralization, HEPA vacuuming, and RCRA disposal. Institutional training mandates exposure monitoring and spill drill proficiency.​

Packaging, Labeling & Storage

Dispensed in light-protective amber vials (PTFE septa, induction seals) within vapor-barrier pouches with silica gel. Labels comply with CLP/GHS, featuring lot/CAS/purity, hazard pictograms, and scannable COA links. Child-resistant caps enhance transport safety.

Store desiccated at 18-22°C, avoiding >50% RH; validated inert atmosphere packaging extends usability. Quarterly stability checks confirm integrity.​

Intended Research Use & Market Positioning

MXPr Powder equips forensic labs for NPS panels (LODs 1-10 ng/mL), R&D for analog synthesis optimization, and academia for dissociative scaffold SAR via binding assays and metabolomics. Toxicology employs it for confirmation standards in Schedule I profiling.

As a novel arylcyclohexylamine, it fills gaps in reference libraries, outperforming custom synthesis with certified traceability and microscale precision for QTOF workflows.

Ordering, Availability & Fulfillment

WooCommerce platform maintains MXPr Powder stock with AES-256 encryption, 3D Secure, and automated lot assignment. Same-day processing ships via compliant carriers (UN 3077, research chemical declaration). Tiered bulk rates and NDA support streamline procurement.​

Client portal delivers tracking, digital COA/SDS, and retest alerts, minimizing research downtime.​

Legal & Regulatory Disclaimer

MXPr Powder is sold strictly for research purposes only, not for human or veterinary use, clinical, diagnostic, or therapeutic applications. Buyers assume complete responsibility for regulatory compliance governing arylcyclohexylamine research chemicals in their jurisdiction. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.